Gastritis – Pipeline Review, H1 2012

Global Markets Direct
May 28, 2012
33 Pages - SKU: GMD3913769
Acne Vulgaris - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Acne Vulgaris - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H2 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acne  |  read more...
USD 2,000
Human Papillomavirus Infections - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Human Papillomavirus Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Human Papillomavirus Infections - Pipeline Review, H2 2014’, provides an overview of the Human Papillomavirus Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Autism - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Autism - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Autism, complete with comparative  |  read more...
USD 2,000
Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic  |  read more...
USD 2,000
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Partial Seizure - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Partial Seizure - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H2 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Partial  |  read more...
USD 2,000
Otitis Media - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Otitis Media - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H2 2014’, provides an overview of the Otitis Media’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Otitis  |  read more...
USD 2,000
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Waldenstrom  |  read more...
USD 2,000
Cardiac Fibrosis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Cardiac Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cardiac Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Cardiac Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiac  |  read more...
USD 2,000
Cardiomyopathy - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Cardiomyopathy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cardiomyopathy - Pipeline Review, H2 2014’, provides an overview of the Cardiomyopathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiomyopathy, complete with comparative  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Site License  USD 1,000  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!